Physiology of intracellular calcium buffering

D Eisner, E Neher, H Taschenberger… - Physiological …, 2023 - journals.physiology.org
Calcium signaling underlies much of physiology. Almost all the Ca2+ in the cytoplasm is
bound to buffers, with typically only∼ 1% being freely ionized at resting levels in most cells …

Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors

M Riccardi, M Pagnesi, O Chioncel… - European Journal of …, 2024 - Wiley Online Library
Cardiogenic shock is a primary cardiac disorder that results in both clinical and biochemical
evidence of tissue hypoperfusion and can lead to multi‐organ failure and death depending …

An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety

M Heringlake, J Alvarez, D Bettex… - Expert Review of …, 2021 - Taylor & Francis
Introduction: In the 20 years since its introduction to the palette of intravenous hemodynamic
therapies, the inodilator levosimendan has established itself as a valuable asset for the …

Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology

A Petraina, C Nogales, T Krahn, H Mucke… - Cardiovascular …, 2022 - academic.oup.com
Mechanism-based therapy centred on the molecular understanding of disease-causing
pathways in a given patient is still the exception rather than the rule in medicine, even in …

Weaning the patient: between protocols and physiology

ME Haaksma, PR Tuinman… - Current Opinion in Critical …, 2021 - journals.lww.com
Current Opinion in Critical Care Log in or Register Subscribe to journalSubscribe Get new issue
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe …

Increased cytosolic calcium buffering contributes to a cellular arrhythmogenic substrate in iPSC-cardiomyocytes from patients with dilated cardiomyopathy

P Jung, F Seibertz, FE Fakuade, N Ignatyeva… - Basic research in …, 2022 - Springer
Dilated cardiomyopathy (DCM) is a major risk factor for heart failure and is associated with
the development of life-threatening cardiac arrhythmias. Using a patient-specific induced …

[HTML][HTML] Drug-induced atrial fibrillation. A narrative review of a forgotten adverse effect

J Tamargo, J Villacastín, R Caballero… - Pharmacological …, 2024 - Elsevier
Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with an
increased morbidity and mortality. There is clinical evidence that an increasing number of …

[HTML][HTML] Understanding the clinical use of levosimendan and perspectives on its future in oncology

E Ribeiro, N Vale - Biomolecules, 2023 - mdpi.com
Drug repurposing, also known as repositioning or reprofiling, has emerged as a promising
strategy to accelerate drug discovery and development. This approach involves identifying …

Evidence and current use of levosimendan in the treatment of heart failure: filling the gap

N Conti, M Gatti, E Raschi, I Diemberger… - Drug Design …, 2021 - Taylor & Francis
Levosimendan is a distinctive inodilator combing calcium sensitization, phosphodiesterase
inhibition and vasodilating properties through the opening of adenosine triphosphate …

Vein of Galen aneurysmal malformation in newborns: a retrospective study to describe a paradigm of treatment and identify risk factors of adverse outcome in a referral …

S Buratti, M Mallamaci, G Tuo, M Severino… - Frontiers in …, 2023 - frontiersin.org
Background Vein of Galen aneurysmal malformation (VGAM) is a rare cerebral vascular
malformation associated with significant morbidity and mortality. Newborns with VGAM …